Publications by authors named "Jeffrey P North"

Regulatory T cells (Tregs) are specialised T lymphocytes that sit at the nexus of immune regulation and tissue repair. While it is appreciated that a substantial number of Tregs are present in healthy human skin, less is known about their microanatomic spatial localisation. Knowledge about the specialised niches that Tregs occupy may aid in rational drug development to treat dermatologic diseases.

View Article and Find Full Text PDF

Background: Erythroderma is a dermatologic condition characterized by widespread red and scaly skin. The causes include, but are not limited to, psoriasis, eczema, drug eruptions, pityriasis rubra pilaris (PRP), and cutaneous T-cell lymphoma. Most of these are typified by Type 2 (e.

View Article and Find Full Text PDF

Background: There are limited surrogate biomarkers to identify the active inflammatory pathway in psoriasis to direct treatment with targeted biologic therapies. We investigated the association of interleukin (IL)-36 epidermal expression, a diagnostic marker of psoriasis, with response to biologic therapy in patients with psoriasis.

Methods: Retrospective immunohistochemical and chart review pilot study.

View Article and Find Full Text PDF

Netherton syndrome (NS) is a rare autosomal recessive disorder that occurs due to a loss-of-function mutation in SPINK5; this loss results in significant inflammation, as well as perturbations of the skin barrier's integrity and functionality. While it is unclear which inflammatory pathways contribute to the development of NS, recent studies have demonstrated the expression of interleukin (IL)-17/IL-36, as well as several Th2 cytokines. Consequently, immunohistochemistry (IHC) with IL-36 may serve as a potential tool for aiding the histopathological diagnosis of this condition.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis is a skin condition linked to high levels of a cytokine called IL-36, which differentiates it from similar skin disorders like pityriasis rosea (PR) and pityriasis lichenoides (PL).
  • A study compared IL-36 immunostaining patterns in 21 cases of PR, 22 cases of PL, and 10 cases of psoriasis, using a grading scale to assess positivity.
  • Results showed all psoriasis cases tested positive for IL-36, while all PR cases were negative, and a significant number of PL cases also had low or negative staining, indicating IL-36 could be a valuable marker for distinguishing these skin conditions.
View Article and Find Full Text PDF

Necrotizing infundibular crystalline folliculitis (NICF) is a rare type of necrotizing folliculitis. The disease typically manifests as folliculocentric papules arising in a seborrheic distribution. Only 23 cases exist in the literature.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied how a treatment blocking a signal called IL-23 helps people with psoriasis, a skin disease.
  • They found that patients who improved had changes in certain immune cells, while those who didn’t improve still showed signs of being sick.
  • The research suggests that for some patients, the treatment needs to be continued because their immune system might not fully recover.
View Article and Find Full Text PDF
Article Synopsis
  • - Primary cutaneous squamous cell carcinoma (cSCC) causes around 10,000 deaths each year in the U.S., and assessing the risk of poor outcomes right at the time of initial biopsy can greatly influence clinical decisions.
  • - A multi-institutional study introduced a self-supervised deep-learning model that can predict the likelihood of poor outcomes in cSCC, revealing that certain histomorphological features like poor differentiation and deep invasion are linked to worse prognoses.
  • - This new model is particularly effective for assessing risk in specific types of cSCC (T2a/T2), which can help identify patients who might need closer monitoring or more aggressive treatment right after diagnosis.
View Article and Find Full Text PDF

Primary cutaneous malignant perivascular epithelioid cell tumor (PEComa) is a rare and potentially aggressive neoplasm. In this article, we report the case of a 34-year-old man who initially presented with a 3-cm mass involving the skin and soft tissue of the right shoulder that, over 3 months, enlarged to 12 cm. Histologic examination of the mass revealed an infiltrative neoplasm with features resembling an undifferentiated pleomorphic sarcoma, including sheets of pleomorphic cells with abundant atypical mitoses and necrosis.

View Article and Find Full Text PDF
Article Synopsis
  • Some regular body processes that help control inflammation don't work right in diseases like psoriasis, which means the inflammation can stay for a long time.
  • Scientists studied skin cells from people with psoriasis and found that there are special genes that can help reduce inflammation, but these genes don't work well in inflamed skin.
  • When they turned off two important genes in these skin cells, they saw a rise in inflammatory markers, showing how these genes are important for keeping inflammation in check, and treatments targeting inflammation might not fix everything when stopped.
View Article and Find Full Text PDF

Identifying genetic variation underlying human diseases establishes targets for therapeutic development and helps tailor treatments to individual patients. Large-scale transcriptomic profiling has extended the study of such molecular heterogeneity between patients to somatic tissues. However, the lower resolution of bulk RNA profiling, especially in a complex, composite tissue such as the skin, has limited its success.

View Article and Find Full Text PDF

Inflammatory conditions represent the largest class of chronic skin disease, but the molecular dysregulation underlying many individual cases remains unclear. Single-cell RNA sequencing (scRNA-seq) has increased precision in dissecting the complex mixture of immune and stromal cell perturbations in inflammatory skin disease states. We single-cell-profiled CD45 immune cell transcriptomes from skin samples of 31 patients (7 atopic dermatitis, 8 psoriasis vulgaris, 2 lichen planus (LP), 1 bullous pemphigoid (BP), 6 clinical/histopathologically indeterminate rashes, and 7 healthy controls).

View Article and Find Full Text PDF

Background: Spindle cell lipomas, pleomorphic lipomas (SCL/PLs), and pleomorphic fibromas (PF) are tumors with loss of retinoblastoma (RB). The latest World Health Organization classification includes a category of atypical spindle cell/pleomorphic lipomatous tumors (ASPLT), which encompasses tumors in this spectrum that show atypical histopathologic features. We have observed PFs that show similar atypical features.

View Article and Find Full Text PDF

Background: Elevated epidermal interleukin (IL)-36 expression distinguishes psoriasis from eczematous dermatitis, but other psoriasiform dermatitides (PDs) have not been thoroughly investigated for IL-36 expression. In this study, we assess the IL-36 staining pattern (IL36-SP) in psoriasis variants and other PDs including lichen simplex chronicus (LSC), prurigo nodularis (PN), lichen planus (LP), tinea, pityriasis rubra pilaris (PRP), mycosis fungoides (MF), pemphigus foliaceus (PF), acute generalized exanthematous pustulosis (AGEP), impetigo (IMP), and syphilis (SY).

Methods: IL-36 immunostaining was performed on 307 cases of psoriasis and various PDs.

View Article and Find Full Text PDF

Distinguishing cellular blue nevi (CBNs) and atypical CBNs from blue nevus-like melanoma (BNLM) can be diagnostically challenging. Immunohistochemistry may inform the diagnosis in a subset of cases but is not always diagnostic. Further, ancillary molecular testing is expensive and often requires significant tissue to complete.

View Article and Find Full Text PDF

Sebaceous neoplasia primarily includes sebaceous adenoma, sebaceoma, and sebaceous carcinoma (SC). Sebaceous adenoma, sebaceoma, and a subset of cutaneous SC are frequently associated with defective DNA mismatch repair resulting from mutations in MLH1, MSH2, or MSH6. These tumors can be sporadic or associated with Muir-Torre syndrome.

View Article and Find Full Text PDF

Background: PReferentially expressed Antigen in MElanoma (PRAME) immunohistochemical (IHC) staining is used to aid melanoma diagnosis. PRAME expression in nevus-associated melanoma (NAM) has not been evaluated.

Methods: PRAME IHC was applied to cases of NAM; staining for each population of melanocytes (benign and malignant) was graded based on the percentage of labeled cells.

View Article and Find Full Text PDF